PMBCX
Price
$30.26
Change
-$0.18 (-0.59%)
Updated
Jun 2 closing price
Net Assets
24.56B
VIMCX
Price
$56.77
Change
+$0.08 (+0.14%)
Updated
Jun 2 closing price
Net Assets
1.82B
Interact to see
Advertisement

PMBCX vs VIMCX

Header iconPMBCX vs VIMCX Comparison
Open Charts PMBCX vs VIMCXBanner chart's image
PMBCX vs VIMCX Comparison Chart in %
View a ticker or compare two or three
VS
PMBCX vs. VIMCX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PMBCX is a Buy and VIMCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PMBCX has more cash in the bank: 24.6B vs. VIMCX (1.83B). PMBCX (0.00) and VIMCX (0.00) have matching dividends . PMBCX was incepted earlier than VIMCX: PMBCX (19 years) vs VIMCX (17 years). PMBCX (1.71) is less costly to investors than VIMCX (1.02). VIMCX is a more actively managed with annual turnover of: 16.00 vs. PMBCX (13.70). PMBCX has a lower initial minimum investment than VIMCX: PMBCX (1000) vs VIMCX (100000). VIMCX annual gain was more profitable for investors over the last year : -5.11 vs. PMBCX (-15.11). VIMCX return over 5 years is better than : 4.08 vs. PMBCX (-9.16).
PMBCXVIMCXPMBCX / VIMCX
Total Expense Ratio1.710.95180%
Annual Report Gross Expense Ratio1.711.02168%
Fund Existence19 years17 years-
Gain YTD-7.252-1.289563%
Front LoadN/AN/A-
Min. Initial Investment10001000001%
Min. Initial Investment IRAN/AN/A-
Net Assets24.6B1.83B1,348%
Annual Yield % from dividends0.000.00-
Returns for 1 year-15.11-5.11296%
Returns for 3 years9.9713.3875%
Returns for 5 years-9.164.08-225%
Returns for 10 years53.20140.5238%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GETGX48.02N/A
N/A
Victory Sycamore Established Value R
BRSDX16.51N/A
N/A
MFS Blended Research Small Cap Eq A
USISX20.28N/A
N/A
Victory Income Stock
CIPSX17.31N/A
N/A
Champlain Small Company Adv
SRFMX12.36N/A
N/A
Sarofim Equity